Titin-based tension in the cardiac sarcomere: Molecular origin and physiological adaptations

Progress in Biophysics and Molecular Biology

Volumn 110, Issue 2-3, 2012, Pages 204-217

  Anderson, Brian R ^a,b   Granzier, Henk L ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Connectin; Entropic force; Mechanical signaling; Passive tension

Indexed keywords

CONNECTIN;

ADAPTATION; ANIMAL; CHEMISTRY; HEART; HUMAN; MECHANICS; METABOLISM; PHYSIOLOGY; SARCOMERE; SIGNAL TRANSDUCTION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CONNECTIN; HEART; HUMANS; MECHANICAL PROCESSES; SARCOMERES; SIGNAL TRANSDUCTION;

EID: 84868101354     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2012.08.003     Document Type: Review

References (122)

1. Anderson, B., Bogomolovas, J., et al., in press.
2. Anderson B.R., Bogomolovas J., et al. The effects of PKCalpha phosphorylation on the extensibility of titin's PEVK element. J. Struct. Biol. 2010, 170(2):270-277.
3. Arber S., Halder G., et al. Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell 1994, 79(2):221-231.
4. Arber S., Hunter J.J., et al. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 1997, 88(3):393-403.
5. Bang M.L., Centner T., et al. The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system. Circ. Res. 2001, 89(11):1065-1072.
6. Belin R.J., Sumandea M.P., et al. Augmented protein kinase C-alpha-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure. Circ. Res. 2007, 101(2):195-204.
7. Bell G.I. Models for the specific adhesion of cells to cells. Science 1978, 200(4342):618-627.
8. Bell S.P., Nyland L., et al. Alterations in the determinants of diastolic suction during pacing tachycardia. Circ. Res. 2000, 87(3):235-240.
9. Bennett P.M., Maggs A.M., et al. The transitional junction: a new functional subcellular domain at the intercalated disc. Mol. Biol. Cell 2006, 17(4):2091-2100.
10. Bianco P., Nagy A., et al. Interaction forces between F-Actin and titin PEVK domain measured with optical tweezers. Biophys. J. 2007, 93(6):2102-2109.
11. Binnig G., Quate C.F., et al. Atomic force microscope. Phys. Rev. Lett. 1986, 56(9):930-933.
12. Bos J.M., Poley R.N., et al. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Mol. Genet. Metab. 2006, 88(1):78-85.
13. Bowman A.L., Catino D.H., et al. The Rho-guanine nucleotide exchange factor domain of obscurin regulates assembly of titin at the Z-disk through interactions with ran binding protein 9. Mol. Biol. Cell 2008, 19(9):3782-3792.
14. Cazorla O., Freiburg A., et al. Differential expression of cardiac titin isoforms and modulation of cellular stiffness. Circ. Res. 2000, 86(1):59-67.
15. Cheng S.M., Cetinkaya M., et al. How sequence determines elasticity of disordered proteins. Biophys. J. 2010, 99(12):3863-3869.
16. Chung C.S., Granzier H.L. Contribution of titin and extracellular matrix to passive pressure and measurement of sarcomere length in the mouse left ventricle. J. Mol. Cell Cardiol. 2011, 50(4):731-739.
17. Chung C.S., Methawasin M., et al. Titin based viscosity in ventricular physiology: an integrative investigation of PEVK-actin interactions. J. Mol. Cell Cardiol. 2011, 51(3):428-434.
18. Cicogna A.C., Robinson K.G., et al. Direct effects of colchicine on myocardial function: studies in hypertrophied and failing spontaneously hypertensive rats. Hypertension 1999, 33(1):60-65.
19. Conrad C.H., Brooks W.W., et al. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 1995, 91(1):161-170.
20. de Tombe P.P., ter Keurs H.E. An internal viscous element limits unloaded velocity of sarcomere shortening in rat myocardium. J. Physiol. 1992, 454:619-642.
21. Dudko O.K., Hummer G., et al. Theory, analysis, and interpretation of single-molecule force spectroscopy experiments. Proc. Natl. Acad. Sci. USA 2008, 105(41):15755-15760.
22. Fabritz L., Fortmüller L., Yu T.Y., Paul M., Kirchhof P. Can preload-reducing therapy prevent disease progression in arrhythmogenic right ventricular cardiomyopathy? Experimental evidence and design of a clinical trial. Prog. Biophys. Mol. Biol. 2012, 110(2-3):340-346.
23. Fowler S.B., Best R.B., et al. Mechanical unfolding of a titin Ig domain: structure of unfolding intermediate revealed by combining AFM, molecular dynamics simulations, NMR and protein engineering. J. Mol. Biol. 2002, 322(4):841-849.
24. Freiburg A., Trombitas K., et al. Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity. Circ. Res. 2000, 86(11):1114-1121.
25. Fukuda N., Wu Y., et al. Phosphorylation of titin modulates passive stiffness of cardiac muscle in a titin isoform-dependent manner. J. Gen. Physiol. 2005, 125(3):257-271.
26. 2+ in skinned myocardium. J. Biomed. Biotechnol. 2010, 2010:727239.
27. Garcia-Manyes S., Brujic J., et al. Force-clamp spectroscopy of single-protein monomers reveals the individual unfolding and folding pathways of I27 and ubiquitin. Biophys. J. 2007, 93(7):2436-2446.
28. Geier C., Gehmlich K., et al. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy. Hum. Mol. Genet. 2008, 17(18):2753-2765.
29. Gotthardt M., Hammer R.E., et al. Conditional expression of mutant M-line titins results in cardiomyopathy with altered sarcomere structure. J. Biol. Chem. 2003, 278(8):6059-6065.
30. Granzier H., Kellermayer M., et al. Titin elasticity and mechanism of passive force development in rat cardiac myocytes probed by thin-filament extraction. Biophys. J. 1997, 73(4):2043-2053.
31. Granzier H.L., Labeit S. Titin and its associated proteins: the third myofilament system of the sarcomere. Adv. Protein Chem. 2005, 71:89-119.
32. Granzier H.L., Radke M.H., et al. Truncation of titin's elastic PEVK region leads to cardiomyopathy with diastolic dysfunction. Circ. Res. 2009, 105(6):557-564.
33. Grater F., Shen J., et al. Mechanically induced titin kinase activation studied by force-probe molecular dynamics simulations. Biophys. J. 2005, 88(2):790-804.
34. Greaser M. Identification of new repeating motifs in titin. Proteins 2001, 43(2):145-149.
35. Greaser M.L., Krzesinski P.R., et al. Developmental changes in rat cardiac titin/connectin: transitions in normal animals and in mutants with a delayed pattern of isoform transition. J. Muscle Res. Cell Motil. 2005, 26(6-8):325-332.
36. Gregorio C.C., Trombitas K., et al. The NH2 terminus of titin spans the Z-disc: its interaction with a novel 19-kD ligand (T-cap) is required for sarcomeric integrity. J. Cell Biol. 1998, 143(4):1013-1027.
37. Gutierrez-Cruz G., Van Heerden A.H., et al. Modular motif, structural folds and affinity profiles of the PEVK segment of human fetal skeletal muscle titin. J. Biol. Chem. 2001, 276(10):7442-7449.
38. Hayashi T., Arimura T., et al. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J. Am. Coll. Cardiol. 2004, 44(11):2192-2201.
39. Helmes M., Trombitas K., et al. Mechanically driven contour-length adjustment in rat cardiac titin's unique N2B sequence: titin is an adjustable spring. Circ. Res. 1999, 84(11):1339-1352.
40. Hidalgo C., Hudson B., et al. PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness. Circ. Res. 2009, 105(7):631-638. 617 pp. following 638.
41. Hudson B.D., Hidalgo C.G., et al. Excision of titin's cardiac PEVK spring element abolishes PKCalpha-induced increases in myocardial stiffness. J. Mol. Cell Cardiol. 2010, 48(5):972-978.
42. Hummer G., Szabo A. Kinetics from nonequilibrium single-molecule pulling experiments. Biophys. J. 2003, 85(1):5-15.
43. Improta S., Politou A.S., et al. Immunoglobulin-like modules from titin I-band: extensible components of muscle elasticity. Structure 1996, 4(3):323-337.
44. Irving T., Li Q., et al. Z/I and A-band lattice spacings in frog skeletal muscle: effects of contraction and osmolarity. J. Muscle Res. Cell Motil. 1998, 19(7):811-823.
45. Irving T., Wu Y., et al. Thick-filament strain and interfilament spacing in passive muscle: effect of titin-based passive tension. Biophys. J. 2011, 100(6):1499-1508.
46. Johannessen M., Moller S., et al. The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell. Mol. Life Sci. 2006, 63(3):268-284.
47. Kabsch W., Mannherz H.G., et al. Atomic structure of the actin:DNase I complex. Nature 1990, 347(6288):37-44.
48. Kellermayer M.S., Smith S.B., et al. Folding-unfolding transitions in single titin molecules characterized with laser tweezers. Science 1997, 276(5315):1112-1116.
49. Kellermayer M.S., Smith S.B., et al. Mechanical fatigue in repetitively stretched single molecules of titin. Biophys. J. 2001, 80(2):852-863.
50. Knoll R., Hoshijima M., et al. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 2002, 111(7):943-955.
51. Kojic S., Medeot E., et al. "The Ankrd2 protein, a link between the sarcomere and the nucleus in skeletal muscle. J. Mol. Biol. 2004, 339(2):313-325.
52. Kong Y., Flick M.J., et al. Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD. Mol. Cell. Biol. 1997, 17(8):4750-4760.
53. Kruger M., Linke W.A. Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension. J. Muscle Res. Cell Motil. 2006, 27(5-7):435-444.
54. Kruger M., Kotter S., et al. Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ. Res. 2009, 104(1):87-94.
55. Labeit S., Kolmerer B. Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science 1995, 270(5234):293-296.
56. Labeit S., Lahmers S., et al. Expression of distinct classes of titin isoforms in striated and smooth muscles by alternative splicing, and their conserved interaction with filamins. J. Mol. Biol. 2006, 362(4):664-681.
57. Lahmers S., Wu Y., et al. Developmental control of titin isoform expression and passive stiffness in fetal and neonatal myocardium. Circ. Res. 2004, 94(4):505-513.
58. Lange S., Auerbach D., et al. Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2. J. Cell Sci. 2002, 115(Pt 24):4925-4936.
59. Lange S., Xiang F., et al. The kinase domain of titin controls muscle gene expression and protein turnover. Science 2005, 308(5728):1599-1603.
60. Leake M.C., Grutzner A., et al. Mechanical properties of cardiac titin's N2B-region by single-molecule atomic force spectroscopy. J. Struct. Biol. 2006, 155(2):263-272.
61. Lee E.H., Gao M., et al. Mechanical strength of the titin Z1Z2-telethonin complex. Structure 2006, 14(3):497-509.
62. Lee E.H., Hsin J., et al. Tertiary and secondary structure elasticity of a six-Ig titin chain. Biophys. J. 2010, 98(6):1085-1095.
63. Li H., Carrion-Vazquez M., et al. Point mutations alter the mechanical stability of immunoglobulin modules. Nat. Struct. Biol. 2000, 7(12):1117-1120.
64. Li H., Oberhauser A.F., et al. Multiple conformations of PEVK proteins detected by single-molecule techniques. Proc. Natl. Acad. Sci. USA 2001, 98(19):10682-10686.
65. Li H., Linke W.A., et al. Reverse engineering of the giant muscle protein titin. Nature 2002, 418(6901):998-1002.
66. Linke W.A., Ivemeyer M., et al. Actin-titin interaction in cardiac myofibrils: probing a physiological role. Biophys. J. 1997, 73(2):905-919.
67. Linke W.A., Kulke M., et al. PEVK domain of titin: an entropic spring with actin-binding properties. J. Struct. Biol. 2002, 137(1-2):194-205.
68. Linke W.A., Grutzner A. Pulling single molecules of titin by AFM - recent advances and physiological implications. Pflug. Arch. Eur. J. Phy. 2008, 456(1):101-115.
69. Lu H., Isralewitz B., et al. Unfolding of titin immunoglobulin domains by steered molecular dynamics simulation. Biophys. J. 1998, 75(2):662-671.
70. Ma K., Kan L., et al. Polyproline II helix is a key structural motif of the elastic PEVK segment of titin. Biochemistry 2001, 40(12):3427-3438.
71. Marino M., Svergun D.I., et al. Poly-Ig tandems from I-band titin share extended domain arrangements irrespective of the distinct features of their modular constituents. J. Muscle Res. Cell Motil. 2005, 26(6-8):355-365.
72. Marko J.F., Siggia E.D. Stretching DNA. Macromolecules 1995, 28:8759-8770.
73. Marszalek P.E., Lu H., et al. Mechanical unfolding intermediates in titin modules. Nature 1999, 402(6757):100-103.
74. Mayans O., van der Ven P.F., et al. Structural basis for activation of the titin kinase domain during myofibrillogenesis. Nature 1998, 395(6705):863-869.
75. Mayans O., Wuerges J., et al. Structural evidence for a possible role of reversible disulphide bridge formation in the elasticity of the muscle protein titin. Structure 2001, 9(4):331-340.
76. McElhinny A.S., Kakinuma K., et al. Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1. J. Cell Biol. 2002, 157(1):125-136.
77. Miller M.K., Bang M.L., et al. The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules. J. Mol. Biol. 2003, 333(5):951-964.
78. Molkentin J.D., Dorn G.W. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu. Rev. Physiol. 2001, 63:391-426.
79. Mrosek M., Labeit D., et al. Molecular determinants for the recruitment of the ubiquitin-ligase MuRF-1 onto M-line titin. Faseb J. 2007, 21(7):1383-1392.
80. Muslin A.J. MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin. Sci. 2008, 115(7-8):203-218.
81. Nagueh S.F., Shah G., et al. Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy. Circulation 2004, 110(2):155-162.
82. Nagy A., Cacciafesta P., et al. Differential actin binding along the PEVK domain of skeletal muscle titin. J. Cell Sci. 2004, 117(Pt 24):5781-5789.
83. Neagoe C., Kulke M., et al. Titin isoform switch in ischemic human heart disease. Circulation 2002, 106(11):1333-1341.
84. Neagoe C., Opitz C.A., et al. Gigantic variety: expression patterns of titin isoforms in striated muscles and consequences for myofibrillar passive stiffness. J. Muscle Res. Cell Motil. 2003, 24(2-3):175-189.
85. Nedrud J., Labeit S., et al. Mechanics on myocardium deficient in the N2B region of titin: the cardiac-unique spring element improves efficiency of the cardiac cycle. Biophys. J. 2011, 101(6):1385-1392.
86. Oberhauser A.F., Hansma P.K., et al. Stepwise unfolding of titin under force-clamp atomic force microscopy. Proc. Natl. Acad. Sci. USA 2001, 98(2):468-472.
87. Ohtsuka H., Yajima H., et al. Binding of the N-terminal 63 kDa portion of connectin/titin to alpha-actinin as revealed by the yeast two-hybrid system. Febs. Lett. 1997, 401(1):65-67.
88. Opitz C.A., Leake M.C., et al. Developmentally regulated switching of titin size alters myofibrillar stiffness in the perinatal heart. Circ. Res. 2004, 94(7):967-975.
89. Pawson T., Scott J.D. Signaling through scaffold, anchoring, and adaptor proteins. Science 1997, 278(5346):2075-2080.
90. Peng J., Raddatz K., et al. Cardiac hypertrophy and reduced contractility in hearts deficient in the titin kinase region. Circulation 2007, 115(6):743-751.
91. Pfuhl M., Pastore A. Tertiary structure of an immunoglobulin-like domain from the giant muscle protein titin: a new member of the I set. Structure 1995, 3(4):391-401.
92. Porter K.E., Turner N.A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Therapeut. 2009, 123(2):255-278.
93. Puchner E.M., Alexandrovich A., et al. Mechanoenzymatics of titin kinase. Proc. Natl. Acad. Sci. USA 2008, 105(36):13385-13390.
94. Radke M.H., Peng J., et al. Targeted deletion of titin N2B region leads to diastolic dysfunction and cardiac atrophy. Proc. Natl. Acad. Sci. USA 2007, 104(9):3444-3449.
95. Rief M., Gautel M., et al. Reversible unfolding of individual titin immunoglobulin domains by AFM. Science 1997, 276(5315):1109-1112.
96. Romer L.H., Birukov K.G., et al. Focal adhesions: paradigm for a signaling nexus. Circ. Res. 2006, 98(5):606-616.
97. Samarel A.M. Costameres, focal adhesions, and cardiomyocyte mechanotransduction. Am. J. Physiol. Heart Circ. Physiol. 2005, 289(6):H2291-H2301.
98. Scholl F.A., McLoughlin P., et al. DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis. J. Cell Biol. 2000, 151(3):495-505.
99. Sheikh F., Raskin A., et al. An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice. J. Clin. Invest. 2008, 118(12):3870-3880.
100. Sorimachi H., Freiburg A., et al. Tissue-specific expression and alpha-actinin binding properties of the Z-disc titin: implications for the nature of vertebrate Z-discs. J. Mol. Biol. 1997, 270(5):688-695.
101. Spencer J.A., Eliazer S., et al. Regulation of microtubule dynamics and myogenic differentiation by MURF, a striated muscle RING-finger protein. J. Cell Biol. 2000, 150(4):771-784.
102. Stacklies W., Vega M.C., et al. Mechanical network in titin immunoglobulin from force distribution analysis. PLoS Comput. Biol. 2009, 5(3):e1000306.
103. Taylor M., Graw S., et al. Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes. Circulation 2011, 124(8):876-885.
104. Trombitas K., Wu Y., et al. Cardiac titin isoforms are coexpressed in the half-sarcomere and extend independently. Am. J. Physiol. Heart Circ. Physiol. 2001, 281(4):H1793-H1799.
105. van Heerebeek L., Borbely A., et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006, 113(16):1966-1973.
106. von Castelmur E., Marino M., et al. A regular pattern of Ig super-motifs defines segmental flexibility as the elastic mechanism of the titin chain. Proc. Natl. Acad. Sci. USA 2008, 105(4):1186-1191.
107. Wang K., Mccarter R., et al. Regulation of skeletal-muscle stiffness and elasticity by titin isoforms - a test of the segmental extension model of resting tension. Proc. Natl. Acad. Sci. USA 1991, 88(16):7101-7105.
108. Warren C.M., Jordan M.C., et al. Titin isoform expression in normal and hypertensive myocardium. Cardiovasc. Res. 2003, 59(1):86-94.
109. Watanabe K., Muhle-Goll C., et al. Different molecular mechanics displayed by titin's constitutively and differentially expressed tandem Ig segments. J. Struct. Biol. 2002, 137(1-2):248-258.
110. Watanabe K., Nair P., et al. Molecular mechanics of cardiac titin's PEVK and N2B spring elements. J. Biol. Chem. 2002, 277(13):11549-11558.
111. Weber K.T. Cardiac interstitium in health and disease: the fibrillar collagen network. J. Am. Coll. Cardiol. 1989, 13(7):1637-1652.
112. Werdich A.A., Brzezinski A., Jeyaraj D., Sabeh M.K., Ficker E., Wan X., MacRae C.A., Rosenbaum D.S. The zebrafish as a novel animal model to study the molecular mechanisms of mechano-electrical feedback in the heart. Prog. Biophys. Mol. Biol. 2012, 110(2-3):154-165.
113. Witt S.H., Granzier H., et al. MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination. J. Mol. Biol. 2005, 350(4):713-722.
114. Witt C.C., Witt S.H., et al. Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. Embo. J. 2008, 27(2):350-360.
115. Wu Y., Cazorla O., et al. Changes in titin and collagen underlie diastolic stiffness diversity of cardiac muscle. J. Mol. Cell Cardiol. 2000, 32(12):2151-2162.
116. Wu Y., Bell S.P., et al. Changes in titin isoform expression in pacing-induced cardiac failure give rise to increased passive muscle stiffness. Circulation 2002, 106(11):1384-1389.
117. Yamasaki R., Berri M., et al. Titin-actin interaction in mouse myocardium: passive tension modulation and its regulation by calcium/S100A1. Biophys. J. 2001, 81(4):2297-2313.
118. Yamasaki R., Wu Y., et al. Protein kinase A phosphorylates titin's cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes. Circ. Res. 2002, 90(11):1181-1188.
119. Young P., Ehler E., et al. Obscurin, a giant sarcomeric Rho guanine nucleotide exchange factor protein involved in sarcomere assembly. J. Cell Biol. 2001, 154(1):123-136.
120. Zhmurov A., Dima R.I., et al. Order statistics theory of unfolding of multimeric proteins. Biophys. J. 2010, 99(6):1959-1968.
121. Zhu Y., Bogomolovas J., et al. Single molecule force spectroscopy of the cardiac titin N2B element: effects of the molecular chaperone alphaB-crystallin with disease-causing mutations. J. Biol. Chem. 2009, 284(20):13914-13923.
122. Zou P., Pinotsis N., et al. Palindromic assembly of the giant muscle protein titin in the sarcomeric Z-disk. Nature 2006, 439(7073):229-233.